Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Pharmacogenetics of Biochemically Verified Abstinence in an Opioid Agonist Therapy Randomized Clinical Trial of Methadone and Buprenorphine/Naloxone

Clinical Pharmacology & Therapeutics(2023)10.1002/cpt.3112Source: DataRank Database

Pharmacogenetics of Biochemically Verified Abstinence in an Opioid Agonist Therapy Randomized Clinical Trial of Methadone and Buprenorphine/Naloxone is a research paper published in Clinical Pharmacology & Therapeutics (2023). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 1.45)OA: bronzeTopics (36)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Meghan J. Chenoweth ORCID,Didier Jutras‐Aswad ORCID,Keith Ahamad,M. Eugenia Socías ORCID,Bernard Le Foll ORCID

Live enrichment

PubMed:38009933 OpenAlex:https://openalex.org/W4389069801

Canadian Institutes of Health Research

Grant: SMN‐139151

Canadian Institutes of Health Research

Grant: SMN‐139150

Canadian Institutes of Health Research

Grant: SMN‐139149

Canadian Institutes of Health Research

Grant: SMN‐139148

CIHR

Grant: SMN-139149

CIHR

Grant: SMN-139150

CIHR

Grant: SMN-139151

CIHR

Grant: SMN-139148

Canadian Institutes of Health Research

Grant: unidentified

unidentified

Michael Smith Foundation for Health Research

Centre for Addiction and Mental Health

FWCI

1.45

Citation Percentile

0.8%

Citation Trend

2025

2026

bronzeLicense: CC BY NC

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.3112

BRONZEhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.3112

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.3112

publisherhttps://ascpt.onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.3112

journalhttps://doi.org/10.1002/cpt.3112

Fields of Study

Opioid Use Disorder TreatmentPain Management and Opioid UseForensic Toxicology and Drug AnalysisMedicine03 medical and health sciences0305 other medical science

MeSH Terms

Buprenorphine, Naloxone Drug CombinationAnalgesics, OpioidBuprenorphineHumansMethadoneNarcotic AntagonistsOpioid-Related DisordersPharmacogeneticsCytochrome P-450 CYP3AOpiate Substitution Treatment

Keywords

MethadoneBuprenorphineMedicineOpioid use disorderOpioid(+)-NaloxonePharmacologyPharmacogeneticsRandomized controlled trialInternal medicineAnesthesiaGenotypeBiologyAnalgesics, OpioidNarcotic AntagonistsOpiate Substitution TreatmentHumansCytochrome P-450 CYP3ABuprenorphine, Naloxone Drug CombinationOpioid-Related Disorders

Sustainable Development Goals

SDG 0: Good health and well-being